Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30005504HIVENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS30026671HIVENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS30026672HIVENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS20000916HPVENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS20046556HPVENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS44012771HTLV-1ENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS44010815HTLV-1ENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS44036114HTLV-1ENSG00000143799.14protein_codingPARP1NoYes142P09874
TCGA Plot Options
Drug Information
GenePARP1
DrugBank IDDB12332
Drug NameRucaparib
Target IDBE0001717
UniProt IDP09874
Regulation Typeinhibitor
PubMed IDs28790837; 27087632
CitationsDockery LE, Gunderson CC, Moore KN: Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer. Onco Targets Ther. 2017 Jun 19;10:3029-3037. doi: 10.2147/OTT.S114714. eCollection 2017.@@Jenner ZB, Sood AK, Coleman RL: Evaluation of rucaparib and companion diagnostics in the PARP inhibitor landscape for recurrent ovarian cancer therapy. Future Oncol. 2016 Jun;12(12):1439-56. doi: 10.2217/fon-2016-0002. Epub 2016 Apr 18.
GroupsApproved; Investigational
Direct Classification2-phenylindoles
SMILESCNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3
Pathways
PharmGKBPA166163418
ChEMBLCHEMBL1173055